| 분자 | Cat. No. | Product Name | 종 | Host | 구조 | 순도 | Activity | 규격 및 가격 |
|---|---|---|---|---|---|---|---|---|
| CXCL14 | Human CXCL14 Protein, His Tag | Human | E. coli | ![]() | SDS-PAGE | $360.00 100ug |
| 영어 이름 | 연구 코드 | 연구 개발 단계 | 회사 | 적응증 | 임상 시험 |
|---|---|---|---|---|---|
| Bexotegrast | PLN-74809 | Phase 3 Clinical | Pliant Therapeutics Inc | Idiopathic Pulmonary Fibrosis; Coronavirus Disease 2019 (COVID-19); Respiratory Distress Syndrome, Adult; Cholangitis, Sclerosing | 상세 |
| IDL-2965 | IDL-2965 | Phase 2 Clinical | Indalo Therapeutics Inc | Metabolic Dysfunction-Associated Steatotic Liver Disease; Idiopathic Pulmonary Fibrosis | 상세 |
| PLN-1474 | PLN-1474 | Phase 1 Clinical | Pliant Therapeutics Inc, Novartis Pharma Ag | Metabolic Dysfunction-Associated Steatotic Liver Disease; Liver Cirrhosis | 상세 |